Navigation Links
Oncolytics Biotech Inc.'s Research Collaborators to Present,REOLYSIN Clinical Trial Data at ASCO Conference

CALGARY, June 01, 2007 /PRNewswire-FirstCall/ - Research collaborators with Oncolytics Biotech Inc. ("Oncolytics") are scheduled to deliver a poster presentation covering REOLYSIN(R) clinical trial data at the American Society of Clinical Oncology (ASCO) Annual Meeting, to be held June 1-5, 2007 in Chicago. The data cover final results of Oncolytics' U.K. Phase I systemic administration trial.

The poster, entitled "Final Results of a Phase I Study of Wild-Type Oncolytic Reovirus Administered Intravenously to Patients with Advanced Cancer" is scheduled to be presented by Dr. James Spicer of The Royal Marsden Hospital and The Institute of Cancer Research, U.K. on Sunday, June 3, 2007.

The poster will be available on the Oncolytics website on Monday, June 4, 2007.

About Oncolytics Biotech Inc.

Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program includes a variety of Phase I and Phase II human trials using REOLYSIN(R), its proprietary formulation of the human reovirus, alone and in combination with radiation or chemotherapy. For further information about Oncolytics, please visit www.oncolyticsbiotech.com.

This press release contains forward-looking statements, within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements, including the implication of the materials to be presented at this meeting with respect to REOLYSIN(R), the Company's expectations related to the results of trials investigating delivery of REOLYSIN(R), and the Company's belief as to the potential of REOLYSIN(R) as a cancer therapeutic, involve known and unknown risks and uncertainties, which could cause the Company's actual results to differ materially from those in the forward-looking sta
'"/>




Page: 1 2

Related medicine technology :

1. Oncolytics Biotech Inc. Announces Positive Clinical Data from U.S. Phase I REOLYSIN Trial
2. Oncolytics Biotech Inc. Research Collaborators Demonstrate Reovirus/Gemcitabine Combination Has Synergistic Effect Against Human Colon Cancer Cell Lines
3. Oncolytics Biotech Inc. Collaborators to Present Reovirus/Gemcitabine Combination Research at AACR Annual Meeting
4. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
5. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
6. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
7. Beike Biotechnology Study Suggests Adult Stem Cells Show Promise for Peripheral Vascular Disease
8. ConjuChem Biotechnologies Reports PC-DAC:Exendin-4 Albumin Conjugate Data Presented at American Diabetes Association Annual Meeting
9. Active Biotech presents new pre-clinical data for the 57-57 project at the 8th World Congress on Inflammation
10. New Positive Pre-clinical Data for Active Biotechs RA Project I-3D
11. Prana Biotechnology Presents New Key Findings on PBT2

Post Your Comments:
(Date:11/23/2009)...ov.23/PRNewswire-FirstCall/-- CryoLife,Inc. (NYSE:...iovasculartissueprocessingcompany,announcedtodayth...ray21stAnnualHealthCareConferenceatTheNewYorkPalac...sidentandchiefexecutiveofficerofCryoLife,Inc.,will...tdevelopmentsandhostaquestionandanswersessionat4:3...
(Date:11/23/2009)...,Tenn.,Nov.23/PRNewswire-FirstCall/-- CumberlandPh...newtop-lineresultsfromastudyevaluatingthesafetyand...feverinhospitalizedburnpatients. ,, Statistical...cingfeverinburnpatientsoverthefirst24hoursoftreatm...orthirddegreeburnscoveringmorethan10percenttotalbo...
(Date:11/23/2009)...IRE,Ill.,Nov.23/PRNewswire/--Sarnova,Inc.,thenatio...intheemergencymedicalservices(EMS)andrespiratoryma...estoitsseniormanagementteam.Thenewexecutivesinclud...executivevicepresidentandgeneralcounsel;SteveLacke...le,executivevicepresidentofcorporatedevelopment. ,...
Breaking Medicine Technology:CryoLife to Present at 21st Annual Piper Jaffray Health Care Conference 2Caldolor(R) (Ibuprofen) Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients 2Caldolor(R) (Ibuprofen) Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients 3Sarnova Expands Senior Management Team 2Cardium Announces Plans to File FDA 510 28k 29 Application for U S Marketing Clearance of ExcellagenXL 28TM 29 Gel for Diabetic Pressure and Venous 14682 1Cardium Announces Plans to File FDA 510 28k 29 Application for U S Marketing Clearance of ExcellagenXL 28TM 29 Gel for Diabetic Pressure and Venous 14682 2Cardium Announces Plans to File FDA 510 28k 29 Application for U S Marketing Clearance of ExcellagenXL 28TM 29 Gel for Diabetic Pressure and Venous 14682 3Cardium Announces Plans to File FDA 510 28k 29 Application for U S Marketing Clearance of ExcellagenXL 28TM 29 Gel for Diabetic Pressure and Venous 14682 4Private Investment Firm Czura Thornton Today Introduces Clearstone Central Laboratories as the Newest Member of the Czura Thornton Life Science Group 5914 1Private Investment Firm Czura Thornton Today Introduces Clearstone Central Laboratories as the Newest Member of the Czura Thornton Life Science Group 5914 2Texas Cardiac Arrhythmia Institute at St Davids Medical Center First in the United States to Utilize Newly FDA Cleared CARTO 28R 29 3 Navigation Syst 5912 1Texas Cardiac Arrhythmia Institute at St Davids Medical Center First in the United States to Utilize Newly FDA Cleared CARTO 28R 29 3 Navigation Syst 5912 2
...shy; May 14, 2007-Acceleron Pharma, Inc., a,biopha...e treatment,of musculoskeletal, metabolic and canc...preclinical study with ACE-031 that,demonstrated t...,and strength in normal mice and in murine models ...egulators of muscle to,increase muscle mass and st...
...BUSINESS WIRE)--May 15, 2007 - Reata,Pharmaceutica...icle,in the May 2007 issue of the journal Cancer R...2 development candidate for cancer,was highly eff...,and that the drug inhibits signaling activity of ...s., The article, "The Novel Triterpenoid C-28 Meth...
Other Medicine Technology:Accelreon Pharma's ACE-031Shown to Increase Muscle Mass in,Preclinical Studies 2Accelreon Pharma's ACE-031Shown to Increase Muscle Mass in,Preclinical Studies 3RTA 402 Shown to Inhibit STAT3 in Animal Model and Holds,Significant Promise for Treating Breast Cancer 2RTA 402 Shown to Inhibit STAT3 in Animal Model and Holds,Significant Promise for Treating Breast Cancer 3
(Date:11/23/2009)... NEW YORK (Nov. 23, 2009) -- A first-of-its-kind c...d online today in the Annals of Surgery . The rep...ional consensus conference -- Diabetes Surgery Sum...than 50 scientific and medical experts agreed on a...that are meant to guide the use and study of gastr...
(Date:11/23/2009)...r. Bernadine Healy, first woman to head the agency..., Nov. 23 (HealthDay News) -- The fallout from las...elay the start of routine mammogram testing for br....S. National Institutes of Health advising women t...erfully ignore them, because unequivocally this wi...
(Date:11/23/2009)..., PartnershipswithMinorityBanksin Washingto...Calif. and Columbia , S.C. IntendedtoSpurEcon...23/PRNewswire-USNewswire/--DaVita,thenation,sleadi...wideMinorityBankInitiativedesignedtocreatejobsands...ntrywithinvestmentsinleadingcommunityandminority-o...
(Date:11/23/2009)..., WASHINGTON,Nov.23/PRNewswire-USNewswire/-- ...nation,slargestindividualmembershipassociationofst...resentativeTimScott forpre-filinga constitutionala...ownhealthcarechoices.SouthCarolinanowbecomesthe24t...ce,legislationmodeledafterALEC,s FreedomofChoicein...
(Date:11/23/2009)..., NEWYORK,Nov.23/PRNewswire/--Howistheeconomy...Saatchi&SaatchiWellnessonWellness&theEcono...rfocusshiftsfromahealthylifestyleofexerciseanddiet...onomicclimate. ,, Thesurvey,smostdramaticfindin...hshiftedfromatraditionalfocusonhealthandwellbeingt...
Breaking Medicine News(10 mins):Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 2Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 3Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 4Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 5Health News:Women Should Ignore New Mammogram Guideline, Ex-NIH Chief Says 2Health News:Women Should Ignore New Mammogram Guideline, Ex-NIH Chief Says 3Health News:DaVita Launches Minority Bank Initiative with $5 Million Investment in Underserved Communities Across the Country 2Health News:DaVita Launches Minority Bank Initiative with $5 Million Investment in Underserved Communities Across the Country 3Health News:South Carolina Now 24th State to Defend Health Care Choice 2Health News:Being Well Is About Reinvention - Not Health 2Health News:Being Well Is About Reinvention - Not Health 3
...inical,Meeting and Exhibition -- Omnicell, Inc., (...tions to acute healthcare facilities, and Brigham ... of Harvard Medical School located in,the heart ...ion management system. With the integration of the...
...od costs, many,families are economizing on groceri...trition. At about 25 cents per 8-ounce glass, on a...y than almost any other beverage option in the,sup...m,their grocery lists, the National got milk? Camp...
... announced today that Dr. Jonathan White will join...Vice President of Haemonetics, effective December ... responsibility for leading development of the nex...As the global leader in blood management solutions...
...tories, Inc. (Nasdaq: IDXX ), today announced th...e Vice President, Instrument Research and Developm... Dr. Brown will oversee instrument development, ma... IDEXX,s strategy of technological innovation in d...
...Sciences, Inc. (Nasdaq: HGSI ) today announced t...he results of ACHIEVE 2/3, its Phase 3 trial of Al...titis C. , , (Logo: http://www.newscom.com/c...am Eastern Time. , , Investors may listen to ...
...irms what we already,know -- that U.S. consumers h...onths. More than one-third have made measurable c... according to Booz & Company (October 2008).,T...re,is a popular myth that fresh produce is too exp...
Other Medicine News:Health News:Brigham and Women's Hospital Selects SinglePointe(TM) Automated Patient-Specific Medication Management Solution from Omnicell 2Health News:Brigham and Women's Hospital Selects SinglePointe(TM) Automated Patient-Specific Medication Management Solution from Omnicell 3Health News:Milk is One Beverage Jackson Can't Afford to Keep Off the Grocery List 2Health News:Milk is One Beverage Jackson Can't Afford to Keep Off the Grocery List 3Health News:Dr. Jonathan White Joins Haemonetics as Head of Research and Development 2Health News:IDEXX Laboratories Names William Brown Corporate Vice President 2Health News:Human Genome Sciences to Sponsor Conference Call 2Health News:Healthy Eating and Good Nutrition Go Hand-in-Hand in Tight Economic Times 2
Pipetman F50
Ovation BioNatural Pipette, one-stroke, fixed volume, 50L
...on is precision, ergonomics, and value!, Comforta... contoured handle , Finer control while pipetting ...ely autoclavable for easy decontamination and ster...y-to-read precision micrometer for reproducible, a...
...pendorf Reference Series 2000 Pipette is a synonym...t and robust design, and superior operating comfor...perate the measuring stroke and blow-out as well a...te/tip" system ensures utmost accuracy and precisi...
Medicine Products: